Massachusetts Financial Services
ESPR

Massachusetts Financial Services’s Esperion Therapeutics ESPR Stock Holding History

Massachusetts Financial Services’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-55,649
Closed -$2.85M – 879
2020
Q2 		$2.85M Sell
55,649
-1,419
-2% -$59.4K ﹤0.01% 660
2020
Q1 		$1.8M Buy
57,068
+9,032
+19% +$477K ﹤0.01% 692
2019
Q4 		$2.86M Sell
48,036
-5,192
-10% -$233K ﹤0.01% 686
2019
Q3 		$1.95M Buy
+53,228
New +$2.11M ﹤0.01% 721
2016
Q1 		– Sell
-133,074
Closed -$2.96M – 846
2015
Q4 		$2.96M Buy
133,074
+93,607
+237% +$2.36M ﹤0.01% 696
2015
Q3 		$932K Sell
39,467
-22
-0.1% -$1.38K ﹤0.01% 762
2015
Q2 		$3.23M Buy
39,489
+14,486
+58% +$1.42M ﹤0.01% 710
2015
Q1 		$2.32M Buy
+25,003
New +$1.61M ﹤0.01% 733

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Massachusetts Financial Services's ESPR Position: Q3 2020 in Review

Massachusetts Financial Services sold out of Esperion Therapeutics (ESPR) in Q3 2020, closing a stake of 55,649 shares — an estimated $2.85M sold.

Massachusetts Financial Services first reported a position in ESPR in Q1 2015 and held it in 8 quarters. The position peaked at $3.23M in Q2 2015. 166 funds tracked by Wall St. Rank hold ESPR as of Q3 2020.

  • Massachusetts Financial Services reported no remaining Esperion Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 55,649 Esperion Therapeutics shares in Q3 2020, an estimated $2.85M.
  • Massachusetts Financial Services first reported a position in Esperion Therapeutics in Q1 2015 and held it in 8 quarters.
  • Massachusetts Financial Services's Esperion Therapeutics position peaked at $3.23M in Q2 2015.
  • 166 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2020.

Based on Massachusetts Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.